Chemical preconditioning escalates chondrogenic activity in explant cultured human dental pulp stem cell study model for future temporomandibular joint regeneration.

National journal of maxillofacial surgery Pub Date : 2024-05-01 Epub Date: 2024-07-24 DOI:10.4103/njms.njms_207_23
Lakshmi Shetty, Pushkar P Waknis, Avinash Kharat, Ramesh Bhonde, Uday Londhe, B M Rudagi, Supriya M Kheur, Kalyani Bhate
{"title":"Chemical preconditioning escalates chondrogenic activity in explant cultured human dental pulp stem cell study model for future temporomandibular joint regeneration.","authors":"Lakshmi Shetty, Pushkar P Waknis, Avinash Kharat, Ramesh Bhonde, Uday Londhe, B M Rudagi, Supriya M Kheur, Kalyani Bhate","doi":"10.4103/njms.njms_207_23","DOIUrl":null,"url":null,"abstract":"<p><strong>Context: </strong>Human dental pulp stem cells (hDPSC) derived from dental pulp in conducive environment activated by chemicals can enhance chondrogenic cells for future animal model temporomandibular joint model.</p><p><strong>Aim: </strong>The study aims at evaluating the chemicals preconditioning (curcumin and rapamycin) efficacy toward chondrogenic proliferation of human dental pulp stem cells.</p><p><strong>Settings and design: </strong>The <i>in vitro</i> study model with 10 premolar teeth extirpated pulp was processed under sterile chemical conditions. The cells viability was checked with calorimetric assay for adipogenic and chondrogenic, osteogenic lineages. The viability of the cells and the concentration of curcumin (CU) and rapamycin (RP) required for cell differentiation toward chondrogenic lineage were assessed.</p><p><strong>Material and methods: </strong>The hDPSC was evaluated after explant long-term cultivation with characterization and chemical conditioning with dimethyl sulfoxide (DMSO) as control. MTT assay was used for cytotoxicity evaluation, cell viability, and proliferation. The dose optimization was observed with RP and CU. Chondrogenic proliferation was assessed with standard staining method of 0.1% Safranin O and 0.1% Alcian blue.</p><p><strong>Statistical design: </strong>The flow cytometry analysis revealed good results for CD 90 compared to others. The intergroup analysis was done by ANOVA, and intragroup analysis was done by <i>Post hoc</i> Tukey's test. The intragroup analysis showed <i>P</i> value < 0.05 for RP in comparison between the various preconditioning agents CU and RP. The dosage of 10 µg/ml RP was considered statistically significant.</p><p><strong>Results: </strong>The flow cytometer analysis revealed good results for CD 90 compared to other surface markers. The dosage of 10 µg/ml RP was having good chondrogenic cell proliferation. The intragroup analysis showed <i>P</i> value < 0.05 for RP in comparison between the various preconditioning agents CU and RP. The calorimetric assay (MTT) quantitative analysis of the chondrogenic cells with Safranin O stain the standard deviation (SD = 0.017 for rapamycin), Alcian blue (SD = 0.49 for RP) in comparison to DMSO (control) and CU.</p><p><strong>Conclusion: </strong>RP activates mTOR pathway and hence stabilizes the stem cell maintenance of human dental pulp stem cell and the dose quantified can be used for future animal temporomandibular joint animal model.</p>","PeriodicalId":101444,"journal":{"name":"National journal of maxillofacial surgery","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11371304/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"National journal of maxillofacial surgery","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4103/njms.njms_207_23","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/7/24 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Context: Human dental pulp stem cells (hDPSC) derived from dental pulp in conducive environment activated by chemicals can enhance chondrogenic cells for future animal model temporomandibular joint model.

Aim: The study aims at evaluating the chemicals preconditioning (curcumin and rapamycin) efficacy toward chondrogenic proliferation of human dental pulp stem cells.

Settings and design: The in vitro study model with 10 premolar teeth extirpated pulp was processed under sterile chemical conditions. The cells viability was checked with calorimetric assay for adipogenic and chondrogenic, osteogenic lineages. The viability of the cells and the concentration of curcumin (CU) and rapamycin (RP) required for cell differentiation toward chondrogenic lineage were assessed.

Material and methods: The hDPSC was evaluated after explant long-term cultivation with characterization and chemical conditioning with dimethyl sulfoxide (DMSO) as control. MTT assay was used for cytotoxicity evaluation, cell viability, and proliferation. The dose optimization was observed with RP and CU. Chondrogenic proliferation was assessed with standard staining method of 0.1% Safranin O and 0.1% Alcian blue.

Statistical design: The flow cytometry analysis revealed good results for CD 90 compared to others. The intergroup analysis was done by ANOVA, and intragroup analysis was done by Post hoc Tukey's test. The intragroup analysis showed P value < 0.05 for RP in comparison between the various preconditioning agents CU and RP. The dosage of 10 µg/ml RP was considered statistically significant.

Results: The flow cytometer analysis revealed good results for CD 90 compared to other surface markers. The dosage of 10 µg/ml RP was having good chondrogenic cell proliferation. The intragroup analysis showed P value < 0.05 for RP in comparison between the various preconditioning agents CU and RP. The calorimetric assay (MTT) quantitative analysis of the chondrogenic cells with Safranin O stain the standard deviation (SD = 0.017 for rapamycin), Alcian blue (SD = 0.49 for RP) in comparison to DMSO (control) and CU.

Conclusion: RP activates mTOR pathway and hence stabilizes the stem cell maintenance of human dental pulp stem cell and the dose quantified can be used for future animal temporomandibular joint animal model.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
化学预处理可提高外植体培养人牙髓干细胞研究模型的软骨活性,用于未来的颞下颌关节再生。
背景:目的:本研究旨在评估化学预处理(姜黄素和雷帕霉素)对人牙髓干细胞软骨增殖的功效:体外研究模型是在无菌化学条件下处理 10 颗前磨牙的牙髓。用量热法检测细胞的成脂、成软骨和成骨系的活力。评估了细胞的活力以及细胞向软骨源系分化所需的姜黄素(CU)和雷帕霉素(RP)浓度:以二甲基亚砜(DMSO)为对照,经过表征和化学调理的外植体长期培养后,对 hDPSC 进行了评估。MTT 试验用于细胞毒性评估、细胞活力和增殖。观察了 RP 和 CU 的剂量优化。用 0.1% Safranin O 和 0.1% Alcian blue 标准染色法评估软骨增殖:流式细胞术分析表明,CD 90与其他药物相比效果良好。组间分析采用方差分析,组内分析采用Tukey's检验。组内分析表明,与各种预处理剂 CU 和 RP 相比,RP 的 P 值小于 0.05。10 µg/ml RP 的剂量被认为具有统计学意义:流式细胞仪分析显示,与其他表面标记物相比,CD 90 的效果很好。剂量为 10 µg/ml 的 RP 具有良好的软骨细胞增殖效果。组内分析显示,与各种预处理剂 CU 和 RP 相比,RP 的 P 值小于 0.05。与 DMSO(对照组)和 CU 相比,用 Safranin O 染色法对软骨细胞进行的热量测定(MTT)定量分析显示,雷帕霉素的标准偏差(SD = 0.017)和 RP 的阿尔新蓝(SD = 0.49):结论:雷帕霉素可激活mTOR通路,从而稳定人牙髓干细胞的干细胞维持能力,其量化剂量可用于未来的动物颞下颌关节动物模型。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
1.20
自引率
0.00%
发文量
0
期刊最新文献
Patterns and characteristics of maxillofacial trauma among children and adolescents: A Bi-institutional retrospective study. Presence of antilingula and its relationship to mandibular foramen-An anatomical study. Primary non-radiation induced angiosarcoma of the parotid with epithelioid morphology. Radiation effects in head and neck and role of hyperbaric oxygen therapy: An adjunct to management. The surgical outcome of sutureless skin closures using Octyl-2-cyanoacrylate (Dermabond™) versus Steri-Strip™.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1